Top Markets
Coin of the day
PCI Biotech Holding ASA PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCIB
株式のランク #40012
PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is... PCI Biotech Holding ASA, an Oslo, Norway-based biopharmaceutical firm, is focused on pioneering and bringing to market innovative treatments for cancer. At the core of their operations is the proprietary photochemical internalization (PCI) technology platform. The company's development pipeline features several distinct therapeutic strategies: fimaCHEM, a novel approach to chemotherapeutic cancer treatment; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is currently in Phase I clinical studies; and fimaNAc, a delivery system for nucleic acid therapeutics, presently in its pre-clinical phase. Furthermore, they provide Amphinex, a photosensitizer known as fimaporfin. PCI Biotech actively participates in joint research endeavors with partners such as Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense.
株価
$0.00733708
最終同期: 2026-04-23
時価総額
$273.87K
変化(1日)
-39.13%
変化(1年)
-94.83%
NO
取引 PCI Biotech Holding ASA (PCIB)

カテゴリー

PCI Biotech Holding ASA(PCIB)の株価履歴
終値の最高値: $0.02 (2026-04-01)

終値の最安値: $1.50 (2008-06-01)
PCI Biotech Holding ASA の株価履歴(2008 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -3.83%
2025 -79.63%
2024 -36.96%
2023 -11.71%
2022 -84.13%
2021 -54.32%
2020 -59.39%
2019 143.06%
2018 1.83%
2017 93.21%
2016 351.92%
2015 -72.20%
2014 -40.12%
2013 -37.49%
2012 -10.04%
2011 -12.25%
2010 321.24%
2009 32.65%
2008 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.15%
KR
$259.89 14.81%
BE